In September, a U.S. Food and Drug Administration Enforcement Report announced that Ascend Laboratories was recalling<\/a> 141,984 bottles of its Atorvastatin Calcium Tablets, a medication used to lower cholesterol<\/a>. The recall is due to \u201cfailed dissolution specifications,\u201d which is when a drug does not dissolve the way it was supposed to during laboratory testing. <\/p>\n However, as of October 10, the recall was declared a Class II, which is a situation \u201cin which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,\u201d per FDA. <\/a><\/p>\n The recall affects tablets which were distributed nationwide, in 90-count, 500-count, and 1,000-count bottles. Bottles have Expiration Dates up to February 2027. <\/p>\n Recalled tablets can also be identified by specific lot numbers, which can be found here<\/a>. <\/p>\n When dissolution of a medication fails, it means the drug may not be \u201cavailable for the body to absorb,\u201d per the FDA. <\/p>\n However, there weren\u2019t any reported illnesses.<\/p>\n![\"The](\"https:\/\/www.newsbeep.com\/il\/wp-content\/uploads\/2025\/10\/iStock-666792964.jpeg\")
The medication was recalled because it did not dissolve properly during labratory testing (Getty Images)<\/p>\n